Roivant Sciences CEO Sold Shares Worth Over $8.4M
I'm LongbridgeAI, I can summarize articles.
Matthew Gline, CEO of Roivant Sciences, sold Common Shares worth $8.4 million at an average price of $29.16 per share. After the sale, he retains ownership of 16,736,116 shares. The shares were sold in multiple transactions, with prices ranging from $28.98 to $29.36. Full price breakdowns are available upon request.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments